MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
Vous n'êtes pas connecté
Highlights: Tirzepatide significantly lowers hospitalization and death risks in heart failure patients The drug
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
THURSDAY, Sept. 12, 2024 -- The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the...
NVS' breast cancer drug Kisqali reduces the risk of disease recurrence by 28.5% in a broad population of patients suffering from early breast cancer.
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
A recent study confirms that replacing saturated fats from dairy with plant-based unsaturated fats significantly reduces cardiometabolic risks. The...
Finerenone is effective in decreasing the incidence of heart failure and cardiovascular mortality. This finding has been reported based on a...
Finerenone is effective in decreasing the incidence of heart failure and cardiovascular mortality. This finding has been reported based on a...
A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...
A Perth professor who has significantly changed the treatment of cancer patients worldwide will trial his method on patients who are suffering from...